BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its new $50 million Greenhouse Fund. They invest in therapeutics, devices, diagnostics and platform technologies focused on human health. Since its first investments in 2003, BioAdvance has become one of the nation's leading investors providing pre-seed and seed-stage funding. To date they have committed more than $40 million to more than 50 seed-stage companies and 17 pre-seed companies.
Philadelphia, Pennsylvania, United StatesFounded 20036+ employeesPrivate
$14.8M raisedGrant· last: grant (Sep 2022)· 1 rounds
